Literature DB >> 6973547

Depression of contact sensitivity to oxazolone by the paramyxovirus of Newcastle disease. Impairment by infectious virus of effector T cells which mediate the response to contactant.

C Caruso, P Palmeri, F Dieli, L Bellina, S Benvegna, E Cillari, A Salerno.   

Abstract

The paramyxovirus of Newcastle disease (NDV) impairs the contact sensitivity to oxazolone in CBA/J mice: in vitro treatment with the infectious virus inhibits the passive transfer of contact sensitivity. Experiments performed with three different virus preparations demonstrate that only the infectious virus is able to inhibit the hypersensitivity reaction while treatment of virus by heat or ultraviolet irradiation wipes out its inhibitory activity. These results suggest that I-NDV depresses the response to oxazolone by its action on T immunoblasts which mediate the response to contactant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973547     DOI: 10.1159/000232804

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Induction and Ly phenotype of suppressor T cells in mice during primary infection with dengue virus.

Authors:  P Y Wong; S Devi; I F McKenzie; K L Yap; T Pang
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

2.  Analysis of the T suppressor cell circuit which regulates contact sensitivity in mice infected with the virus of Newcastle disease.

Authors:  A Salerno; G Colonna Romano; F Dieli; V Colizzi
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

3.  Impairment of contrasuppressor activity in mice infected with the paramyxovirus of Newcastle disease.

Authors:  F Dieli; G Colonna Romano; D Zingone; A Salerno
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system.

Authors:  G Colonna Romano; F Dieli; S Abrignani; A Salerno; V Colizzi
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.